Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

First Affiliated Hospital Xi'an Jiaotong University: Clinical Trials & FDA Approval Profile

First Affiliated Hospital Xi'an Jiaotong University (Global / Institutional) sponsors 16 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 4 active protocols (3 recruiting now), 1 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)0.0%
Median Closed Enrollment vs National (145 pts)70 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for First Affiliated Hospital Xi'an Jiaotong University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)16
Active Pipeline (Recruiting Now)4 (3)
Completed vs Stopped Early1 / 0 (0.0%)
Median Closed Actual Enrollment70 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With First Affiliated Hospital Xi'an Jiaotong University
Hospital Research SiteLocationShared Protocols
The First Affiliated Hospital of Xi 'an Jiaotong UniversityXi'an, Shaanxi3
The First Hospital of Lanzhou UniversityLanzhou, Gansu2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by First Affiliated Hospital Xi'an Jiaotong University
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07389460Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)Phase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the First Affiliated Hospital Xi'an Jiaotong University Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI